We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Report: FDA Barely Misses Drug Development Goals in Fiscal 2008
Report: FDA Barely Misses Drug Development Goals in Fiscal 2008
April 22, 2010
The FDA fell short of meeting some sponsor-related goals in fiscal 2008, including scheduling meetings with sponsors to review NDAs and BLAs, responding to special protocol assessment (SPA) requests and responding to clinical holds.